Back

IN SILICO DRUG DISCOVERY FOR NDM -1 METALLO β LACTAMASE INHIBITORS for KLEBSIELLA PUEUMONIAE

S, R.; P, R.; E, P.; A, Y. B.; S, V.; E, R.; Priya, V. G. S.

2025-08-21 bioinformatics
10.1101/2025.08.16.670670 bioRxiv
Show abstract

In every region of the world, antibiotic resistance is increasing to dangerously high levels. Our ability to cure widespread infectious diseases is being threatened by the emergence of new resistance mechanisms. Klebsiella pneumoniae is one of the most prevalent nosocomial Gram-negative bacteria in the world. NDM-1 is a brand-new class of metallo-{beta}-lactamase (MBL) that makes the bacteria almost total resistant to all {beta}-lactam antibiotics, including penicillins, cephalosporins and carbapenems. Dangerous infections could develop if NDM-1 switches to a bacterium that is already resistant to antibiotics. It could be untreatable and spread quickly among humans. Using the available insilico tools, in the present research work, an attempt has been made to develop inhibitors for NDM-1 {beta} Lactamase of K. pneumoniae. In the present study, 8 standard ligands were identified and docked against the NDM-1 protein using PyRx. Among these standards, Sulfonamide was selected as the best compound and virtual screening of a large number of sulfonamide moieties was conducted with the identified active site in NDM-1 protein using PyRx. On analyzing the obtained results, about 60 molecules were selected as best hits for Docking studies and ADMET studies. On analyzing the ADMET properties and binding energies of the top hits, (3Z)-N-hydroxypenta-1,3-diene-2-sulfonamide (Pubchem CID 118156306) and N-hydroxyfuran-2-sulfonamide (Pubchem CID 46175386). Molecular dynamics simulations were carried out on the complxes formed by these 2 compounds with target protein and the results showed the complexes were stable which validated the earlier findings. Based on the findings of the study, it was concluded that (3Z)-N-hydroxypenta-1,3-diene-2-sulfonamide (Pubchem CID 118156306) and N-hydroxyfuran-2-sulfonamide (Pubchem CID 46175386) had the potential to be used as lead candidates against infections caused by K. pneumoniae producing NDM-1 strains.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 11%
15.1%
2
RSC Advances
18 papers in training set
Top 0.1%
8.7%
3
Scientific Reports
3102 papers in training set
Top 16%
6.6%
4
Journal of Biomolecular Structure and Dynamics
43 papers in training set
Top 0.2%
5.0%
5
Molecules
37 papers in training set
Top 0.1%
5.0%
6
ACS Omega
90 papers in training set
Top 0.2%
5.0%
7
Journal of Medical Virology
137 papers in training set
Top 0.8%
3.7%
8
Life Sciences
25 papers in training set
Top 0.3%
2.1%
50% of probability mass above
9
Archives of Clinical and Biomedical Research
28 papers in training set
Top 0.5%
1.9%
10
International Journal of Molecular Sciences
453 papers in training set
Top 6%
1.8%
11
PeerJ
261 papers in training set
Top 6%
1.8%
12
Journal of Chemical Information and Modeling
207 papers in training set
Top 2%
1.8%
13
Frontiers in Microbiology
375 papers in training set
Top 5%
1.7%
14
Antibiotics
32 papers in training set
Top 0.7%
1.7%
15
Briefings in Bioinformatics
326 papers in training set
Top 4%
1.7%
16
Frontiers in Molecular Biosciences
100 papers in training set
Top 2%
1.4%
17
Pharmaceuticals
33 papers in training set
Top 1.0%
1.3%
18
Informatics in Medicine Unlocked
21 papers in training set
Top 0.6%
1.3%
19
Acta Pharmaceutica Sinica B
11 papers in training set
Top 0.6%
1.0%
20
BioMed Research International
25 papers in training set
Top 3%
0.9%
21
Heliyon
146 papers in training set
Top 4%
0.9%
22
International Journal of Biological Macromolecules
65 papers in training set
Top 3%
0.9%
23
Computational and Structural Biotechnology Journal
216 papers in training set
Top 8%
0.8%
24
Frontiers in Medicine
113 papers in training set
Top 6%
0.8%
25
Genomics
60 papers in training set
Top 2%
0.8%
26
Gigabyte
60 papers in training set
Top 2%
0.7%
27
PLOS Neglected Tropical Diseases
378 papers in training set
Top 6%
0.7%
28
Frontiers in Pharmacology
100 papers in training set
Top 5%
0.7%
29
ACS Pharmacology & Translational Science
40 papers in training set
Top 1%
0.7%
30
European Journal of Pharmacology
11 papers in training set
Top 0.6%
0.5%